Latanoprostene bunod
Modify Date: 2024-01-03 13:15:32
Latanoprostene bunod structure
|
Common Name | Latanoprostene bunod | ||
|---|---|---|---|---|
| CAS Number | 860005-21-6 | Molecular Weight | 507.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H41NO8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Latanoprostene bunodLatanoprostene bunod (LBN), a nitric oxide (NO)-donating prostaglandin F2a analog, is a topical ophthalmic therapeutic for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT) [1]. |
| Name | 4-nitrooxybutyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate |
|---|---|
| Synonym | More Synonyms |
| Description | Latanoprostene bunod (LBN), a nitric oxide (NO)-donating prostaglandin F2a analog, is a topical ophthalmic therapeutic for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT) [1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H41NO8 |
|---|---|
| Molecular Weight | 507.62 |
| Exact Mass | 507.28300 |
| PSA | 142.04000 |
| LogP | 4.28970 |
| NCX-116 |
| UNII-I6393O0922 |
| Latanoprostene BUNOD |